title: Oseltamivir and its active metabolite cross the placenta at significant levels.
authors.forename: Wouter J
authors.initials: WJ
authors.lastname: Meijer
authors.forename: Hein W
authors.initials: HW
authors.lastname: Bruinse
authors.forename: Marcel P H
authors.initials: MP
authors.lastname: van den Broek
authors.forename: Wiete
authors.initials: W
authors.lastname: Kromdijk
authors.forename: Annemarie M J
authors.initials: AM
authors.lastname: Wensing
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D002853:Chromatography, Liquid; D005260:Female; D005312:Fetal Blood / Q000737:chemistry; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy*; D053139:Oseltamivir / Q000008:administration & dosage / Q000493:pharmacokinetics*; D010920:Placenta / Q000502:physiology*; D010949:Plasma / Q000737:chemistry; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D053719:Tandem Mass Spectrometry
chemical_list: D000998:Antiviral Agents; D053139:Oseltamivir